P-113d, an Antimicrobial Peptide Active against Pseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients

Antimicrobial peptides are a source of novel agents that could be useful for treatment of the chronic lung infections that afflict cystic fibrosis (CF) patients. Efficacy depends on antimicrobial activity against the major pathogens of CF patients, Pseudomonas aeruginosa, Staphylococcus aureus, and...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Sajjan, Umadevi S., Tran, Linh T., Sole, Nuria, Rovaldi, Christopher, Akiyama, Alan, Friden, Phillip M., Forstner, Janet F., Rothstein, David M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90850/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709321/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3437-3444.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!